Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper

Citation
S. Baldwin et al., Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper, J EUR A D V, 15, 2001, pp. 5-11
Citations number
23
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
ISSN journal
09269959 → ACNP
Volume
15
Year of publication
2001
Supplement
1
Pages
5 - 11
Database
ISI
SICI code
0926-9959(200109)15:<5:SBFCTA>2.0.ZU;2-R
Abstract
Background Diaper dermatitis is a common childhood affliction. Aiming to he lp reduce the prevalence of this problem, we have advanced in our developme nt of a novel diaper that delivers dermatological formulations to help prot ect the skin from over-hydration and irritation. Objective To determine the clinical benefits of a novel disposable diaper d esigned to deliver a zinc oxide and petrolatum-based formulation continuous ly to the skin during use. Methods All studies were independent, blinded, randomized clinical trials. Study A was conducted to confirm transfer of the zinc oxide/petrolatum (ZnO / Pet) formulation from the diaper to the child's skin during use. Childre n wore a single diaper for 3 h or multiple diapers for 24 h. After the use period, stratum corneum samples were taken from each child and analysed for ZnO / Pet. Study B evaluated the prevention of skin irritation and barrier damage from a standard skin irritant (SLS) in an adult arm model. Study C evaluated skin erythema and diaper rash in 268 infants over a 4-week usage period. One half of the infants used the ZnO / Pet diaper, while the other half used a control diaper that was identical except for the absence of the ZnO / Pet formulation. Results The ointment formulation and ZnO transferred effectively from the d iaper to the child's skin during product use. Transfer of ZnO increased fro m 4.2 mug/cm(2) at 3 h to > 8 mug/cm(2) at 24 h. Exposure to the formulatio ns directly on adult skin prior to an irritant challenge was associated wit h up to a 3.5 reduction in skin barrier damage and skin erythema. Greatest reductions were seen for the ZnO containing formulations. Wearing of the fo rmulation treated diaper was also associated with a significant reduction i n skin erythema and diaper rash compared to the control product. Conclusions The results demonstrated the clinical benefits associated with continuous topical administration of a zinc oxide / petrolatum-based formul ation by this novel diaper.